Among more than 230,000 cardiac patients who had sustained a heart attack or undergone one of two common heart procedures, only 16 percent participated in a formal exercise program after their hospitalization – despite the program’s demonstrated benefits to health.

Astellas Pharma, and Seattle Genetics recently began dosing the first patient in a registrational, phase two clinical trial of enfortumab vedotin for patients with certain forms of urothelial bladder cancer.

To discover potential correlations between contact with nature and health conditions, researchers at Seattle’s University of Washington (UW) recently posed the question “how do you measure a ‘dose’ of nature?” with a focus on lifestyle and environmental planning.

A study published in JAMA Cardiology found that people who live in predominately black neighborhoods are less likely than those in white areas to receive CPR or defibrillation from a bystander when suffering from cardiac arrest, which leads to a higher risk of death, an article in University of Washington-Harborview (UW) Heath Sciences Newsbeat said.

Using computer-generated protein inserted into stem cells, scientists at the University of Washington (UW) in Seattle recently found they could change the cells’ epigenetic (non-genetically sourced) memory, potentially leading to progress in the treatment of cancer and aging-related issues.

The Paul G. Allen Frontiers Group is forming a center at the University of Washington that will map cell development in organisms.

SCI Solutions said in a release it has upgraded its health care scheduling solution, Schedule Maximizer. The cloud-based enterprise health care scheduling platform provides a seamless system for health providers.

University of Washington (UW) researchers are closer to unlocking remedies for some primary infectious diseases after identifying protein structures in 70 organisms.

The American Heart Association said it is partnering with The Paul G. Allen Frontiers Group to offer two $1.5 million grants to fund heart disease research as part of the AHA-Allen Distinguished Investigator awards.

A substantial number of Democrats in the Senate want to work with Republicans over likely changes to the Affordable Care Act (ACA), the chairman of the committee that oversees health issues has revealed.

Alder BioPharmaceuticals Inc. recently released the positive top-line data results from two of its clinical trials, which assessed ALD403, a proprietary monoclonal antibody product candidate to prevent migraines.

U.S. Sens. Patty Murray (D-WA) and Ron Wyden (D-OR), along with   other Democratic senators, unveiled legislation recently to protect Medicare beneficiaries and states from a spike in Part B premiums and deductibles in 2016.